ConvaTec Group Plc (CNVVY)
USD 13.29
(8.92%)
USD 13.29
(8.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.2 Billion USD | 3.97% |
| 2022 | 1.15 Billion USD | 19.01% |
| 2021 | 971.7 Million USD | -1.16% |
| 2020 | 983.1 Million USD | -17.3% |
| 2019 | 1.18 Billion USD | -10.54% |
| 2018 | 1.32 Billion USD | -13.35% |
| 2017 | 1.53 Billion USD | 1.46% |
| 2016 | 1.51 Billion USD | -53.14% |
| 2015 | 3.22 Billion USD | -3.43% |
| 2014 | 3.34 Billion USD | -5.11% |
| 2013 | 3.52 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.3 Billion USD | 1.62% |
| 2024 Q1 | 1.29 Billion USD | 7.64% |
| 2023 Q4 | 1.2 Billion USD | 0.69% |
| 2023 Q3 | 1.19 Billion USD | -14.01% |
| 2023 Q2 | 1.38 Billion USD | 1.51% |
| 2023 FY | 1.2 Billion USD | 3.97% |
| 2023 Q1 | 1.36 Billion USD | 18.3% |
| 2022 Q2 | 1.16 Billion USD | 1.7% |
| 2022 Q4 | 1.15 Billion USD | 1.76% |
| 2022 FY | 1.15 Billion USD | 19.01% |
| 2022 Q3 | 1.13 Billion USD | -2.56% |
| 2022 Q1 | 1.14 Billion USD | 18.01% |
| 2021 Q3 | 954.9 Million USD | -7.39% |
| 2021 Q4 | 971.7 Million USD | 1.76% |
| 2021 FY | 971.7 Million USD | -1.16% |
| 2021 Q2 | 1.03 Billion USD | 1.27% |
| 2021 Q1 | 1.01 Billion USD | 3.57% |
| 2020 FY | 983.1 Million USD | -17.3% |
| 2020 Q1 | 1.11 Billion USD | -6.61% |
| 2020 Q4 | 983.1 Million USD | 1.25% |
| 2020 Q2 | 1.12 Billion USD | 1.5% |
| 2020 Q3 | 971 Million USD | -13.83% |
| 2019 Q1 | 1.27 Billion USD | -3.7% |
| 2019 FY | 1.18 Billion USD | -10.54% |
| 2019 Q4 | 1.18 Billion USD | 1.57% |
| 2019 Q3 | 1.17 Billion USD | -9.79% |
| 2019 Q2 | 1.29 Billion USD | 1.45% |
| 2018 Q3 | 1.32 Billion USD | -9.3% |
| 2018 FY | 1.32 Billion USD | -13.35% |
| 2018 Q2 | 1.46 Billion USD | 0.0% |
| 2018 Q1 | 1.46 Billion USD | -4.54% |
| 2018 Q4 | 1.32 Billion USD | 0.02% |
| 2017 FY | 1.53 Billion USD | 1.46% |
| 2017 Q1 | 1.5 Billion USD | -0.29% |
| 2017 Q2 | 1.5 Billion USD | -0.05% |
| 2017 Q3 | 1.53 Billion USD | 1.75% |
| 2017 Q4 | 1.53 Billion USD | 0.05% |
| 2016 Q3 | 1.51 Billion USD | -59.95% |
| 2016 FY | 1.51 Billion USD | -53.14% |
| 2016 Q4 | 1.51 Billion USD | 0.04% |
| 2016 Q2 | 3.77 Billion USD | -1.9% |
| 2016 Q1 | 3.84 Billion USD | 19.24% |
| 2015 Q3 | 3.82 Billion USD | -0.83% |
| 2015 Q4 | 3.22 Billion USD | -15.74% |
| 2015 FY | 3.22 Billion USD | -3.43% |
| 2015 Q2 | 3.86 Billion USD | 3.11% |
| 2015 Q1 | 3.74 Billion USD | -6.97% |
| 2014 Q4 | 4.02 Billion USD | -4.27% |
| 2014 Q1 | 4.5 Billion USD | 0.88% |
| 2014 Q2 | 4.51 Billion USD | 0.18% |
| 2014 FY | 3.34 Billion USD | -5.11% |
| 2014 Q3 | 4.2 Billion USD | -6.91% |
| 2013 Q2 | 4.43 Billion USD | 0.95% |
| 2013 Q3 | 5.68 Billion USD | 28.15% |
| 2013 Q1 | 4.39 Billion USD | 0.0% |
| 2013 FY | 3.52 Billion USD | 0.0% |
| 2013 Q4 | 4.46 Billion USD | -21.41% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -250571.871% |
| Ansell Limited | -54.99 Million USD | 2286.124% |
| Ansell Limited | -55.1 Million USD | 2282.033% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 3394.589% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 1144036.367% |
| Psykey, Inc. | 634.59 Thousand USD | -189360.016% |
| ConvaTec Group Plc | 1.2 Billion USD | -0.141% |
| Encision Inc. | 1.29 Million USD | -93051.509% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -51976.543% |
| Innovative MedTech Inc. | 1.76 Million USD | -68029.171% |
| LifePoint, Inc. | -3.26 Million USD | 36934.935% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -24415.811% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -55510.546% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 2776517.883% |
| Reflect Scientific, Inc. | -1.03 Million USD | 116229.805% |
| SmileDirectClub, Inc. | 778.67 Million USD | -54.403% |
| Sector 10, Inc. | 163 Thousand USD | -737507.362% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 387.939% |
| SheerVision, Inc. | 57.34 Thousand USD | -2096362.013% |
| United Health Products, Inc. | 660.56 Thousand USD | -181909.752% |
| Vasamed, Inc. | 22.12 Thousand USD | -5434761.224% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -45593.65% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -155582.079% |